William Blair downgraded Paragon 28 (FNA) to Market Perform from Outperform without a price target after the company entered into a definitive agreement for Zimmer Biomet to acquire all its outstanding shares for $13.00 in cash, corresponding to an equity value of approximately $1.1B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FNA: